Pharmacologic consequences of cholesterol absorption inhibition: alteration in cholesterol metabolism and reduction in plasma cholesterol concentration induced by the synthetic saponin beta-tigogenin cellobioside (CP-88818; tiqueside).

Source:http://linkedlifedata.com/resource/pubmed/id/8468523

Download in:

View as

General Info

PMID
8468523